Serial Number
99016157
Owner
Theaprin Pharmaceuticals, Inc.Attorney
Constance B. StefanouFiling Date
Jan 23, 2025
INTRAVASA Trademark
Serial Number: 99016157
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Constance B. Stefanou Morgan, Lewis & Bockius LLP
1111 Pennsylvania Avenue, NW
Washington DC, DC 20004
United States
Trademark Details
Filing Date
January 23, 2025
Registration Date
Not Registered
Published for Opposition
February 10, 2026
Goods & Services
Antioxidants for medical purposes, namely, antioxidants for use in the manufacture of pharmaceuticals, antioxidants for use in the manufacture of food supplements
Health and medical information services, namely, providing information to physicians, healthcare professionals and patients on research of pharmaceutical products; Veterinary health and medical information services, namely, providing information to veterinarians, medical professionals and owners on research of pharmaceutical products
Health and medical information services, namely, providing information to physicians, healthcare professionals and patients on diagnostic, prophylactic and therapeutic properties of pharmaceutical products; Veterinary health and medical information services, namely, providing information to veterinarians, medical professionals and owners on diagnostic, prophylactic and therapeutic properties of pharmaceutical products
Antipyretic, analgesic, and anti-inflammatory preparations; Veterinary preparations, namely, antipyretics, analgesics, anti-inflammatories preparations and antioxidants; Pharmaceutical preparations for the treatment of COVID-19 cytokine storm as adjunctive therapy, acute myocardial infarction, acute thrombotic stroke, Mild to Moderate pain and Moderate to Severe Pain
